A detailed history of Quantbot Technologies LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 101,543 shares of BHC stock, worth $889,516. This represents 0.04% of its overall portfolio holdings.

Number of Shares
101,543
Holding current value
$889,516
% of portfolio
0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.22 - $8.26 $530,054 - $838,745
101,543 New
101,543 $827,000
Q1 2024

May 06, 2024

BUY
$7.77 - $10.61 $116,705 - $159,362
15,020 New
15,020 $159,000
Q4 2022

Feb 13, 2023

BUY
$6.09 - $7.93 $11,644 - $15,162
1,912 Added 3.24%
60,955 $382,000
Q3 2022

Nov 07, 2022

BUY
$4.58 - $9.21 $100,856 - $202,813
22,021 Added 59.48%
59,043 $406,000
Q2 2022

Aug 09, 2022

BUY
$7.06 - $23.63 $261,375 - $874,829
37,022 New
37,022 $309,000
Q1 2022

May 16, 2022

SELL
$21.6 - $27.79 $75,470 - $97,098
-3,494 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$23.0 - $29.01 $80,362 - $101,360
3,494 New
3,494 $96,000
Q3 2021

Nov 09, 2021

SELL
$25.04 - $30.06 $585,710 - $703,133
-23,391 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$27.43 - $32.7 $82,619 - $98,492
3,012 Added 14.78%
23,391 $685,000
Q1 2021

May 14, 2021

SELL
$21.37 - $34.38 $172,242 - $277,102
-8,060 Reduced 28.34%
20,379 $646,000
Q4 2020

Feb 12, 2021

BUY
$15.31 - $21.12 $46,465 - $64,099
3,035 Added 11.95%
28,439 $591,000
Q3 2020

Nov 16, 2020

BUY
$14.88 - $20.13 $378,011 - $511,382
25,404 New
25,404 $394,000
Q1 2020

May 13, 2020

SELL
$12.98 - $30.25 $22,935 - $53,451
-1,767 Closed
0 $0
Q4 2019

Feb 10, 2020

SELL
$18.89 - $31.89 $55,555 - $93,788
-2,941 Reduced 62.47%
1,767 $52,000
Q3 2019

Nov 12, 2019

BUY
$20.88 - $25.66 $98,303 - $120,807
4,708 New
4,708 $102,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.17B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.